Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marlies S Reimers

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of Surgical Oncology|October 2, 2015
Influence of Individual Surgeon Volume on Oncological Outcome of Colorectal Cancer SurgeryMarleen Buurma, Hidde M Kroon, Marlies S Reimers, et al.
Nature Reviews. Clinical Oncology|June 25, 2014
How does genome sequencing impact surgery?Marlies S Reimers, Charla C Engels, Peter J K Kuppen, et al.
Gastroenterology Report|April 25, 2014
Biomarkers in precision therapy in colorectal cancerMarlies S Reimers, Eliane C M Zeestraten, Peter J K Kuppen, et al.
BMC Cancer|July 7, 2014
Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort studyMarlies S Reimers, Charla C Engels, Hein Putter, et al.
Molecular Medicine (Cambridge, Mass.)|December 31, 2015
The Prognostic Value of Microsatellite Instability, <i>KRAS, BRAF</i> and <i>PIK3CA</i> Mutations in Stage II Colon Cancer PatientsF Jeroen Vogelaar, Felice N van Erning, Marlies S Reimers, et al.
Biomarkers in Cancer|November 2, 2013
The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistryEliane C M Zeestraten, Anne Benard, Marlies S Reimers, et al.
British Journal of Cancer|November 3, 2018
Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) dataAnne Trinh, Claudia Lädrach, Heather E Dawson, et al.
Journal of the National Cancer Institute|September 29, 2014
Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patientsMarlies S Reimers, Peter J K Kuppen, Mark Lee, et al.
Journal of the American Geriatrics Society|November 27, 2012
Aspirin use after diagnosis improves survival in older adults with colon cancer: a retrospective cohort studyMarlies S Reimers, Esther Bastiaannet, Myrthe P P van Herk-Sukel, et al.
Plos One|January 27, 2017
The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer DiagnosisMartine A Frouws, Marlies S Reimers, Marloes Swets, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Surgical Oncology|October 2, 2015
Influence of Individual Surgeon Volume on Oncological Outcome of Colorectal Cancer SurgeryMarleen Buurma, Hidde M Kroon, Marlies S Reimers, et al.
Nature Reviews. Clinical Oncology|June 25, 2014
How does genome sequencing impact surgery?Marlies S Reimers, Charla C Engels, Peter J K Kuppen, et al.
Gastroenterology Report|April 25, 2014
Biomarkers in precision therapy in colorectal cancerMarlies S Reimers, Eliane C M Zeestraten, Peter J K Kuppen, et al.
BMC Cancer|July 7, 2014
Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort studyMarlies S Reimers, Charla C Engels, Hein Putter, et al.
Molecular Medicine (Cambridge, Mass.)|December 31, 2015
The Prognostic Value of Microsatellite Instability, <i>KRAS, BRAF</i> and <i>PIK3CA</i> Mutations in Stage II Colon Cancer PatientsF Jeroen Vogelaar, Felice N van Erning, Marlies S Reimers, et al.
Biomarkers in Cancer|November 2, 2013
The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistryEliane C M Zeestraten, Anne Benard, Marlies S Reimers, et al.
British Journal of Cancer|November 3, 2018
Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) dataAnne Trinh, Claudia Lädrach, Heather E Dawson, et al.
Journal of the National Cancer Institute|September 29, 2014
Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patientsMarlies S Reimers, Peter J K Kuppen, Mark Lee, et al.
Journal of the American Geriatrics Society|November 27, 2012
Aspirin use after diagnosis improves survival in older adults with colon cancer: a retrospective cohort studyMarlies S Reimers, Esther Bastiaannet, Myrthe P P van Herk-Sukel, et al.
Plos One|January 27, 2017
The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer DiagnosisMartine A Frouws, Marlies S Reimers, Marloes Swets, et al.
Pageof 2